The role of cardiovascular magnetic resonance in the evaluation of patients with heart failure

Expert Review of Cardiovascular Therapy

Volumn 2, Issue 1, 2004, Pages 53-59

  Prasad, S K ^a   Kotwinski, P ^a   Assomul, R ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Cardiovascular magnetic resonance; Etiology; Function; Gadolinium; Viability

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM; GADOLINIUM PENTETATE; PENTETIC ACID;

CHAGAS DISEASE; CONGESTIVE CARDIOMYOPATHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FABRY DISEASE; HEALTH SERVICE; HEART FAILURE; HEART FUNCTION; HEART PERFUSION; HEART VENTRICLE SIZE; HEART VENTRICLE VOLUME; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IRON OVERLOAD; ISCHEMIC HEART DISEASE; MEDICAL ASSESSMENT; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; MYOCARDITIS; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATIENT CARE; REPRODUCIBILITY; REVIEW; SARCOIDOSIS; STANDARD; CONGESTIVE HEART FAILURE; HEART VENTRICLE FUNCTION; MAGNETIC RESONANCE ANGIOGRAPHY; METHODOLOGY; PHYSIOLOGY;

CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; CONTRAST MEDIA; HEART FAILURE, CONGESTIVE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE IMAGING, CINE; VENTRICULAR FUNCTION;

EID: 2342436345     PISSN: 14779072     EISSN: None     Source Type: Journal    
DOI: 10.1586/14779072.2.1.53     Document Type: Review

References (42)

1. Mosterd A, Hoes AW, de Bruyne MC et al. Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur. Heart J. 20, 447-455 (1999).
2. Lips DJ, deWindt LJ, van Kraaij DJ et al. Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy. Eur. Heart J. 24, 883-896 (2003).
3. Nagel F, Schneider U, Schalla S et al. Magnetic resonance real-time imaging for the evaluation of left ventricular function. J. Cardiovasc. Magn. Reson. 2, 7-14 (2000).
4. Yang PC, Kerr AB, Liu AC et al. New real time interactive magnetic resonance imaging system complements echocardigraphy. J. Am. Coll. Cardiol. 32, 2049-2056 (1998).
5. Poon M, Fuster V, Fayad Z. Cardiac magnetic resonance imaging: a "one-stop-shop" evaluation of myocardial dysfunction. Curr. Opin. Cardiol. 17, 663-670 (2002).
6. Bellenger NG, Burgess MI, Ray SG et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance: are they interchangeable? Eur. Heart J. 21, 1387-1396 (2000).
7. Grothues F, Smith GC, Moon JC et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am. J. Cardiol. 90, 29-34 (2002).
8. Goldstein HA, Kashanian FK, Blumetti RF et al. Safety assessment of gadopentetate dimeglumine in U.S. clinical trials. Radiology 174, 17-23 (1990)
9. Rehr RB, Malloy CR, Filipchuk NG et al. Left ventricular volumes measured by MR imaging. Radiology 156, 717-719 (1985).
10. Bellenger NG, Gatehouse PD, Rajappan K et al. Left ventricular quantification in heart failure by cardiovascular MR using prospective respiratory navigator gating: comparison with breath-hold acquisition. J. Magn. Reson. Imaging 11, 411-417 (2000).
11. Epstein FH, Wolff SD, Arai AE. Segmented κ-space fast cardiac imaging using an echo-train readout. Magn. Reson. Med. 41, 609-613 (1999).
12. Lorenz CH, Flacke S, Fischer SE. Noninvasive imaging modalities. Cardiac MR imaging. Cardiol. Clin. 18, 557-570 (2000).
13. Matter C, Nagel E, Stuber M et al. Assessment of systolic and diastolic LV function by MR myocardial tagging. Basic Res. Cardiol. 91 (Suppl. 2), 23-28 (1996).
14. Nagel E, Lehmkuhl HB, Bocksch W et al. Noninvasive diagnosis of ischemia induced wall motion abnormalities with the use of high dose dobutamine stress MRI. Comparison with dobutamine stress echocardiography. Circulation 99, 763-770 (1999).
15. Bogaert J, Rademakers FE. Regional nonuniformity of normal adult human left ventricle. Am. J. Physiol. Heart Circ. Physiol. 281, H610-H620 (2001).
16. Young AA, Axel L. Three dimensional motion and deformation of the heart wall: estimation with spatial modulation of magnetisation - a model based approach. Radiologv 185, 241-247 (1992).
17. Kim RJ, Wu E, Rafael A et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N. Engl. J. Med. 343, 1445-1453 (2000).
18. Bello D, Shah DJ, Farah GM et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing b-blocker therapy. Circulation 108, 1945-1953 (2003).
19. Kim RJ, Fieno DS, Parrish TB et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100, 1992-2002 (1999).
20. Wu KC, Zerhouni EA, Judd RM et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 97, 765-772 (1998).
21. Klein C, Nekolla SG, Bengel FM et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 105, 162-167 (2002).
22. Wilke N, Jerosch-Herold M, Wang Y et al. Myocardial perfusion reserve: assessment with multisection quantitative, first pass MR imaging. Radiology 204, 373-384 (1997).
23. Panting JR, Gatehouse PD, Yang GZ et al. Echo planar magnetic resonance myocardial perfusion imaging: parametric map analysis and comparison with thallium. SPECT. J. Magn. Reson. Imaging 13, 192-200 (2001).
24. Lauerma Y, Virtanen KS, Sipila LM et al. Multislice MRI in assessment of myocardial perfusion in patients with single-vessel proximal left anterior descending coronary artery disease before and after revascularization. Circulation 96, 2859-2867 (1997).
25. Ibrahim T, Nekolla SG, Schreiber K et al. Assessment of coronary flow reserve: comparison between contrast-enhanced magnetic resonance imaging and positron emission tomography. J. Am. Coll. Cardiol. 39, 864-870 (2002).
26. Waller C, Hiller KH, Voll S et al. Myocardial perfusion imaging using a noncontrast agent MR imaging technique. Int. J. Cardiovasc. Imaging. 17, 123-132 (2001).
27. Kim WY, Danias PG, Stuber M et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N. Engl. J. Med. 345, 1863-1869 (2001).
28. Mazur W, Brucks S, Darty SN et al. Magnetic resonance imaging in detection and functional assessment of coronary artery disease. Curr. Atheroscler. Rep. 4, 128-133 (2002).
29. Taylor AM, Thorne S, Rubens MB et al. Coronary artery imaging in congenital heart disease: complementary role of magnetic resonance and x-ray coronary angiography. Circulation 101, 1670-1678 (2000).
30. Galjee MA, Van Rossum AC, Coesburg T et al. Value of magnetic resonance imaging in assessing patency and function of coronary artery bypass grafts. Circulation 93, 660-666 (1996).
31. Li D, Deshpande V. Magnetic resonance imaging of coronary arteries. Top Magn. Reson. Imaging 12, 337-347 (2001).
32. Mogelvang J, Stokholm KH, Saunamaki K et al. Assessment of left ventricular volumes by magnetic resonance in comparison with radionuclide angiography, contrast angiography and echocardiography. Eur. Heart J. 13, 1677-1683 (1992).
33. Wiesmann F, Engelhardt S, Ruff J et al. Reduced contractile reserve and diastolic dysfunction in a transgenic mouse model with β -1 adrenergic receptor overexpression assessed by MRI. Circulation 100, I-565 (1999).
34. Bellenger NG, Davies LC, Francis JM et al. Reduction in Sample Size for Studies of Remodeling in Heart Failure by the Use of Cardiovascular Magnetic Resonance. J. Cardiovasc. Magn. Reson 2, 271-280 (2000).
35. McCrohon JA, Moon JC, Prasad SK et al. Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium-Enhanced Cardiovascular Magnetic Resonance. Circulation 108, 54-59 (2003).
36. Choudhury I, Mahrholdt H, Wagner A et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 40, 2156-2164 (2002).
37. Moon JC, McKenna W, Smith GC et al. Myocardial fibrosis imaging in hypertrophic cardiomyopathy using gadolinium enhanced magnetic resonance imaging: correlation with risk of arrhythmia and progressive disease. J. Am Coll. Cardiol. 39, 389 (2002).
38. Anderson LJ, Holden S, Davis B et al. Cardiovascular T2 magnetic resonance for the early diagnosis of myocardial iron overload. Eur. Heart J. 22, 2171-2179 (2001).
39. Wacker P, Halperin DS, Balmer-Ruedin D et al. Regression of cardiac insufficiency after ambulatory intravenous deferoxamine in thalassemia major. Chest 103, 1276-1278 (1993).
40. Schulz-Menger J, Strohm O, Dietz R et al. Visualization of cardiac involvement in patients with systemic sarcoidosis applying contrast-enhanced magnetic resonance imaging. MAGMA 11, 82-83 (2000).
41. Friedrich MG, Strohm O, Schutz-Menger J et al. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 97, 1802-1809 (1998).
42. Schroeder AP, Houlind K, Pedersen EM et al. Magnetic resonance imaging seems safe in patients with intracoronary stents. J. Cardiovasc. Magn. Reson. 2, 43-49 (2000).